Prognostic impact of trisomies of chromosomes and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)

Journal of Clinical Oncology

Volumn 18, Issue 9, 2000, Pages 1876-1887

  Heerema, Nyla A ^a   Sather, Harland N ^a   Sensel, Martha G ^a   Zhang, Tracy ^a   Hutchinson, Raymond J ^a   Nachman, James B ^a   Lange, Beverly J ^a   Steinherz, Peter G ^a   Bostrom, Bruce C ^a   Reaman, Gregory H ^a   Gaynon, Paul S ^a   Uckun, Fatih M ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER GROWTH; CHILD; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 5; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POLYPLOIDY; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; TRISOMY;

EID: 17444441536     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.9.1876     Document Type: Article

References (50)

1. Clavell LA, Gelber RD, Cohen HJ, et al: Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 315:657-663, 1986
2. Chessells JM, Bailey C, Richards SM: Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of U.K. Medical Research Council trial UKALL X - Medical Research Council Working Party on Childhood Leukaemia. Lancet 345:143-148, 1995
3. Eden OB, Lilleyman JS, Richards S, et al: Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol 78:187-196, 1991
4. Lange B, Sather H, Weetman R, et al: Double delayed intensification improves outcome in moderate risk pediatric acute lymphoblastic leukemia (ALL): A Children's Cancer Group study (CCG-1891). Blood 90:559a, 1997 (abstr)
5. Nachman JB, Sather HN, Sensel MG, et al: Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 338:1663-1671, 1998
6. Nachman J, Sather HN, Cherlow JM, et al: Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the Children's Cancer Group. J Clin Oncol 16:020-430, 1998
7. Pui CH, Mahmoud HH, Rivera GK, et al: Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 92:411-415, 1998
8. Riehm H, Gadner H, Henze G, et al: Results and significance of six randomized trials in four consecutive ALL-BFM studies. Hamatol Bluttransfus 33:439-450, 1990
9. Steinherz P, Gaynon P, Breneman J, et al: Treatment of acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: Randomized control trial from the Children's Cancer Group. Cancer 82:600-612, 1998
10. Tubergen DG, Gilchrist GS, O'Brien RT, et al: Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Children's Cancer Group phase III trial. J Clin Oncol 11:527-537, 1993
11. Smith M, Arthur D, Camitta B, et al: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18-24, 1996
12. Third International Workshop on Chromosomes in Leukemia (1980): Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Genet Cytogenet 4:111-137, 1981
13. Third International Workshop on Chromosomes in Leukemia: Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res 43:868-873, 1983
14. Secker-Walker LM, Chessells JM, Stewart EL, et al: Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: A long-term follow-up. Br J Haematol 72:336-342, 1989
15. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237-2251, 1993
16. Look AT, Roberson PK, Williams DL, et al: Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 65:1079-1086, 1985
17. Trueworthy R, Shuster J, Look T, et al: Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 10:606-613, 1992
18. Bloomfield CD, Secker-Walker LM, Goldman AI, et al: Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 40:171-185, 1989
19. Raimondi SC, Roberson PK, Pui CH, et al: Hyperdiploid (47-50) acute lymphoblastic leukemia in children. Blood 79:3245-3252, 1992
20. Chessels JM, Swansbury GJ, Reeves B, et al: Cytogenetics and prognosis in childhood lymphoblastic leukaemia: Results of MRC UKALL X - Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol 99:93-100, 1997
21. Heerema N, Sather H, Reaman G, et al: cytogenetic studies of acute lymphoblastic leukemia: Clinical correlations results from the Children's Cancer Group. J Assoc Genet Technol 24:206-212, 1998
22. Raimondi SC, Pui CH, Hancock ML, et al: Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 10:213-224, 1996
23. Jackson JF, Boyett J, Pullen J, et al: Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6: A Pediatric Oncology Group study. Cancer 66:1183-1189, 1990
24. Harris MB, Shuster JJ, Carroll A, et al: Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study. Blood 79:3316-3324, 1992
25. Uckun FM, Muraguchi A, Ledbetter JA. et al: Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 73:1000-1015, 1989
26. Uckun FM, Reaman GH, Steinherz PG, et al: Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Children's Cancer Group study. Leuk Lymphoma 24:57-70, 1996
27. Hutchinson R, Bertolone S, Cooper H, et al: Early marrow response predicts outcome for patients with low risk ALL: Results of CCG-1881. Proc Am Soc Clin Oncol 13:319, 1994 (abstr)
28. Bostrom B, Gaynon P, Sather H, et al: Dexamethasone (DEX) decreases central nervous system (CNS) relapse in lower risk acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 17:527a, 1998 (abstr 2024)
29. Reaman GH, Sposto R, Sensel MG, et al: Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 17:445-455, 1999
30. Heerema NA, Palmer CG, Baehner RL: Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. Cancer Genet Cytogenet 17:165-179, 1985
31. Mitelman F (ed): ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
32. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
33. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
34. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
35. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
36. Gaynon PS, Desai AA, Bostrom BC, et al: Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review. Cancer 80:1717-1726, 1997
37. Groupe Francais de Cytogenetique Hematologique: Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 7:10-19, 1993
38. Rubnitz JE, Behm FG, Wichlan D, et al: Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia 13:19-21, 1999
39. Seeger K, Adams HP, Buchwald D, et al: TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Munster Study Group. Blood 91:1716-1722, 1998
40. Raimondi SC, Shurtleff SA, Downing JR, et al: 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood 90:4559-4566, 1997
41. Heerema NA, Stork L, Crotty M-L, et al: TEL-AML1 expression in childhood acute lymphoblastic leukemia (ALL) is associated with rapid early response (RER) to induction chemotherapy. Blood 94:503a, 1994 (abstr)
42. Whitehead VM, Vuchich MJ, Lauer SJ, et al: Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 80:1316-1323, 1992
43. Heerema NA, Sather HN, Sensel MG, et al: Low hyperdiploidy (47-50 chromosomes) in pediatric acute lymphoblastic leukemia (ALL). Blood 94:502a, 1999 (abstr)
44. Uckun FM, Kersey JH, Gajl Peczalska KJ, et al: Heterogeneity of cultured leukemia lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients. J Clin Invest 80:639-646, 1987
45. Kaspers GJ, Smets LA, Pieters R, et al: Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study. Blood 85:751-756, 1995
46. Synold TW, Relling MV, Boyett JM, et al: Blast cell methotrexate-polyglutatnate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 94:1996-2001, 1994
47. Chu E, Allegra C: Antifolates, in Chabner B, Long D (eds): Cancer Chemotherapy and Biotherapy (ed 2). Philadelphia, PA, Lippincott-Raven, 1996
48. Zhang L, Taub JW, Williamson M, et al: Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: Relationship to immunophenotype and ploidy. Clin Cancer Res 4:2169-2177, 1998
49. Belkov VM, Krynetski EY, Schuetz JD, et al: Reduced folate carrier expression in acute lymphoblastic leukemia: A mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood 93:1643-1650, 1999
50. Ito C, Kumagai M, Manabe A, et al: Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis. Blood 93:315-320, 1999